Real‐World Associations Between Renin‐Angiotensin‐Aldosterone System Inhibition Therapy, Hyperkalemia, and Outcomes: A Clinical and Scientific Call to Action

Detalles Bibliográficos
Autores principales: Chapman, Arlene, Gunning, Samantha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915277/
https://www.ncbi.nlm.nih.gov/pubmed/31711386
http://dx.doi.org/10.1161/JAHA.119.014845
_version_ 1783479978647617536
author Chapman, Arlene
Gunning, Samantha
author_facet Chapman, Arlene
Gunning, Samantha
author_sort Chapman, Arlene
collection PubMed
description
format Online
Article
Text
id pubmed-6915277
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69152772019-12-23 Real‐World Associations Between Renin‐Angiotensin‐Aldosterone System Inhibition Therapy, Hyperkalemia, and Outcomes: A Clinical and Scientific Call to Action Chapman, Arlene Gunning, Samantha J Am Heart Assoc Original Research John Wiley and Sons Inc. 2019-11-12 /pmc/articles/PMC6915277/ /pubmed/31711386 http://dx.doi.org/10.1161/JAHA.119.014845 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Chapman, Arlene
Gunning, Samantha
Real‐World Associations Between Renin‐Angiotensin‐Aldosterone System Inhibition Therapy, Hyperkalemia, and Outcomes: A Clinical and Scientific Call to Action
title Real‐World Associations Between Renin‐Angiotensin‐Aldosterone System Inhibition Therapy, Hyperkalemia, and Outcomes: A Clinical and Scientific Call to Action
title_full Real‐World Associations Between Renin‐Angiotensin‐Aldosterone System Inhibition Therapy, Hyperkalemia, and Outcomes: A Clinical and Scientific Call to Action
title_fullStr Real‐World Associations Between Renin‐Angiotensin‐Aldosterone System Inhibition Therapy, Hyperkalemia, and Outcomes: A Clinical and Scientific Call to Action
title_full_unstemmed Real‐World Associations Between Renin‐Angiotensin‐Aldosterone System Inhibition Therapy, Hyperkalemia, and Outcomes: A Clinical and Scientific Call to Action
title_short Real‐World Associations Between Renin‐Angiotensin‐Aldosterone System Inhibition Therapy, Hyperkalemia, and Outcomes: A Clinical and Scientific Call to Action
title_sort real‐world associations between renin‐angiotensin‐aldosterone system inhibition therapy, hyperkalemia, and outcomes: a clinical and scientific call to action
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915277/
https://www.ncbi.nlm.nih.gov/pubmed/31711386
http://dx.doi.org/10.1161/JAHA.119.014845
work_keys_str_mv AT chapmanarlene realworldassociationsbetweenreninangiotensinaldosteronesysteminhibitiontherapyhyperkalemiaandoutcomesaclinicalandscientificcalltoaction
AT gunningsamantha realworldassociationsbetweenreninangiotensinaldosteronesysteminhibitiontherapyhyperkalemiaandoutcomesaclinicalandscientificcalltoaction

Ejemplares similares